The Roles of Tissue Factor in Malignant Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agnes Lee, MD
Hamilton Health Sciences and McMaster University
Study Chair - James Perry, MD
Toronto Sunnybrook Regional Cancer Centre
Principal Investigator - Janusz Rak
Hamilton Health Sciences and McMaster University
Principal Investigator - Jeffrey Weitz, MD
Hamilton Health Sciences and McMaster University
Principal Investigator - Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Principal Investigator - William Geerts, MD
Sunnybrook Health Sciences Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto-Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Henry Ford Hospital
Detroit, Michigan, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2004
- Primary completion
- —
- Completion
- 31 Oct 2006
- Last update posted
- 6 Apr 2017
- Registered enrollment
- 30
- Registry id
- NCT00201903
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.